Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
But after a protracted stand-off with the federal government, the drug's manufacturer, Eli Lilly, declared it would not proceed with the PBS process, airing a cluster of grievances, including that the price Australia was willing to pay for the drug was too low
The drug is the second GLP-1 pill approved by federal regulators for weight loss and the first that doesn't require fasting or meal timing
Additional benefits
Pricing reflects PlexusDx published rates as of April 2026
US$ 26.03
US$ 29.76
US$ 28.86
